Consent for Genomic Epidemiology in Developing Countries: Added human subject protection also needed
2007

Consent for Genomic Epidemiology in Developing Countries

publication

Author Information

Author(s): Reinhard Robert

Primary Institution: San Francisco Vaccine Trials Unit

Conclusion

Stronger protections and benefits for participants are necessary alongside improved consent in genomic epidemiology.

Supporting Evidence

  • Privacy protections under HIPAA have exceptions that may not apply internationally.
  • Safeguards should include restrictions on vulnerable populations and prohibitions on misuse of data.

Takeaway

When collecting genetic information, it's important to protect people's privacy and make sure they benefit from the research.

Potential Biases

There are risks of stigmatization and misuse of genetic data.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0040214

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication